Literature DB >> 32610859

Clinical Profile of Covid-19 Infected Patients Admitted in a Tertiary Care Hospital in North India.

Sudhir Bhandari1, Abhishek Bhargava1, Shrikant Sharma2, Prakash Keshwani1, Raman Sharma1, Subrata Banerjee1.   

Abstract

BACKGROUND: The novel coronavirus (Covid-19) continues to wreck havoc across China, European countries, USA and now seems to gain a strong foothold in India. The aim of this report is to describe the clinical profiles of these Covid-19 infected patients admitted in Sawai Mansingh Hospital(S.M.S), Jaipur ranging from their age, sex, travel history, clinical symptoms, laboratory evaluation, radiological characteristics, treatment provided along with common side effects and the final outcome. The described cases are one of the earliest cases of Covid-19 in the Indian subcontinent.
METHODS: Epidemiological, clinical, laboratory, and radiological characteristics and treatment and outcomes data were obtained with data collection forms from electronic medical records and history given by 21 Covid-19 infected patients admitted in S.M.S., Jaipur. Patients were tested for Covid-19 by real-time reverse transcription polymerase chain reaction (RT-PCR) assay of 2019-nCoVRNA. RESULTS AND DISCUSSION: During the course of this study 21 Covid-19 positive patients were admitted in S.M.S Hospital, Jaipur. Male patients constituted 66.66% of total patients and majority of the patients (80.90%) were below 60 years of age. Most of the patients (71.40%) were either foreigners or had a history of foreign travel suggesting that these cases were not community acquired except for 4 cases from textile producing district Bhilwara (known as Manchester of India), an epicenter of North India. Approximately 33.33% patients were completely asymptomatic and of those who were symptomatic cough was the most common symptom (85.71%) followed by fever (78.57%), myalgia (64.28%), headache (28.57%) and dyspnea (28.57%). Three patients (14.28 %) had underlying co morbidity in the form of hypertension, diabetes mellitus, hypothyroidism, chronic kidney disease or coronary artery disease. 11 patients (52.38%) had lymphopenia in their hemogram during the course of admission. 3 patients (14.28%) had leucocytosis and 4 patients (19.04%) presented with thrombocytopenia. All 4 patients in the severe category had raised FDP, D-Dimer levels and they needed oxygen support. These patients had deranged liver functions and had elevated pro-calcitonin levels, serum ferritin levels and LDH levels. 1 out of the these 4 cases went into ARDS during the course of treatment. 10 patients yielded negative results for Covid-19. The mean duration from admission to getting 1st Covid-19 sample negative was 8.3 days. 18 patients (85.71%) are still under treatment.
CONCLUSION: Clinical investigations in initial Covid-19 patients in the Indian subcontinent reveal lymphopenia as predominant finding in hemogram. Patients with older age and associated comorbid conditions (COPD and diabetes) seem to have greater risk for lung injury thereby requiring oxygen support during the course of disease and these patients also had greater derangement in their biochemical profile. © Journal of the Association of Physicians of India 2011.

Entities:  

Mesh:

Year:  2020        PMID: 32610859

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  16 in total

1.  Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India.

Authors:  Shiv Lal Soni; Kamal Kajal; L N Yaddanapudi; Pankaj Malhotra; Goverdhan Dutt Puri; Ashish Bhalla; Mini P Singh; Inderpaul Singh Sehgal; Vipin Koushal; Neelam Varma; Manisha Biswal; P V M Lakshmi; Sadhna Sharma; Vikas Suri; Z Deepy; Sant Ram; Jaivinder Yadav; Navin Pandey; Prashant Sharma; Nabhajit Malik; Kapil Goyal; Aseem Mehra; Swapnajeet Sahoo; Ritin Mohindra; Jijo Francis; Mudit Bhargava; Karan Singla; Preena Babu; Amiy Verma; Niranjan Shiwaji Khaire; R R Guru
Journal:  Indian J Med Res       Date:  2021 Jan & Feb       Impact factor: 2.375

2.  Clinical spectrum and outcome of patients visiting coronavirus screening centre in North India and clinical predictors for COVID-19.

Authors:  Neeraj Singla; Rudresh Gowda; Ritin Mohindra; Vikas Suri; Deba Prasad Dhibar; Navneet Sharma
Journal:  J Family Med Prim Care       Date:  2021-01-30

3.  Procalcitonin (in COVID-19): The Incessant Quest.

Authors:  Raymond D Savio
Journal:  Indian J Crit Care Med       Date:  2021-01

Review 4.  Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review.

Authors:  Sibtain Ahmed; Lena Jafri; Zahra Hoodbhoy; Imran Siddiqui
Journal:  Indian J Crit Care Med       Date:  2021-01

Review 5.  Comprehensive study on clinical responses and socioeconomic characteristics of COVID-19 patients during outbreak.

Authors:  Nishtha Singh; Pratishtha Singh; Vineeta Singh; Akhilesh Krishna; Shraddha Singh
Journal:  J Family Med Prim Care       Date:  2021-11-29

6.  Clinical profile and outcomes of COVID-19 positive patients -A cross sectional study.

Authors:  Christina Karthaka; Sulakshana S Baliga; Padmaja R Walvekar
Journal:  J Family Med Prim Care       Date:  2021-11-29

7.  Clinical features and mortality in COVID-19 SARI versus non COVID-19 SARI cases from Western Rajasthan, India.

Authors:  Ankur Sharma; Nikhil Kothari; Akhil Dhanesh Goel; Balakrishnan Narayanan; Shilpa Goyal; Pradeep Bhatia; Deepak Kumar; Gopal Krishna Bohra; Nishant Kumar Chauhan; Ramniwas Jalandra; Naveen Dutt; Pankaj Bhardwaj; Mahendra Kumar Garg; Sanjeev Misra
Journal:  J Family Med Prim Care       Date:  2021-09-30

8.  Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19.

Authors:  Ali Sharifpour; Sepideh Safanavaei; Rabeeh Tabaripour; Fatemeh Taghizadeh; Maryam Nakhaei; Atikeh Abadi; Mahdi Fakhar; Elham Sadat Banimostafavi; Eisa Nazar; Masoud Aliyali; Siavash Abedi; Hossein Mehravaran; Zakaria Zakariaei; Hossein Azadeh
Journal:  Ann Med Surg (Lond)       Date:  2021-06-24

Review 9.  Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension.

Authors:  Sarama Saha; Sasanka Chakrabarti; Praveen Kumar Singh; Jit Poddar; Soumitra Satapathi; Surendra Saini; Sham S Kakar; Partha Roy
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 6.692

Review 10.  Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression.

Authors:  Vedika Bhat; Swapnil Borse; Preeti Chavan-Gautam; Kalpana Joshi
Journal:  J Ayurveda Integr Med       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.